Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised Phase III Trial of Neoadjuvant Aromatase Inhibitors in Postmenopausal ER-positive Breast Cancer
2006-000513-37Phase 3Completed
- Sponsor
- American College of Surgeons Oncology Group
- Start
- May 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in breast cancer comparing Anastrozole arm, Letrozole arm and Exemestane arm (3 arms). Primary endpoint: Primary objective. Started May 2006; status: completed.
02
Drugs
anastrozoleletrozoleexemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2006-000513-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000513-37.